Atika Capital Management LLC Has $27.29 Million Stake in Intuitive Surgical, Inc. $ISRG

Atika Capital Management LLC grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 55,100 shares of the medical equipment provider’s stock after acquiring an additional 1,500 shares during the quarter. Intuitive Surgical comprises approximately 3.8% of Atika Capital Management LLC’s investment portfolio, making the stock its 7th largest holding. Atika Capital Management LLC’s holdings in Intuitive Surgical were worth $27,289,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of ISRG. Brighton Jones LLC increased its holdings in shares of Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after acquiring an additional 731 shares in the last quarter. Bank Pictet & Cie Europe AG increased its holdings in shares of Intuitive Surgical by 0.5% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider’s stock valued at $99,678,000 after acquiring an additional 883 shares in the last quarter. Dark Forest Capital Management LP increased its holdings in shares of Intuitive Surgical by 110.8% during the fourth quarter. Dark Forest Capital Management LP now owns 3,566 shares of the medical equipment provider’s stock valued at $1,861,000 after acquiring an additional 1,874 shares in the last quarter. RiverPark Advisors LLC increased its holdings in shares of Intuitive Surgical by 94.4% during the fourth quarter. RiverPark Advisors LLC now owns 8,711 shares of the medical equipment provider’s stock valued at $4,547,000 after acquiring an additional 4,231 shares in the last quarter. Finally, Burling Wealth Partners LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter valued at about $584,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insiders Place Their Bets

In other news, insider Gary S. Guthart sold 2,800 shares of the stock in a transaction that occurred on Monday, July 28th. The stock was sold at an average price of $495.24, for a total transaction of $1,386,672.00. Following the transaction, the insider owned 18,520 shares in the company, valued at $9,171,844.80. This trade represents a 13.13% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Myriam Curet sold 4,500 shares of the stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares in the company, valued at $173,845.44. This trade represents a 92.73% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 15,839 shares of company stock worth $7,896,972. Corporate insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the topic of several recent analyst reports. Erste Group Bank restated a “hold” rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Wells Fargo & Company upped their target price on Intuitive Surgical from $559.00 to $599.00 and gave the company an “overweight” rating in a research report on Wednesday, July 23rd. Evercore ISI upped their target price on Intuitive Surgical from $470.00 to $550.00 and gave the company an “in-line” rating in a research report on Tuesday, July 8th. Citigroup reiterated a “buy” rating and issued a $650.00 target price (up previously from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Finally, Robert W. Baird dropped their target price on Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 23rd. Thirteen research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $595.95.

Intuitive Surgical Trading Up 0.3%

Intuitive Surgical stock opened at $480.45 on Thursday. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The stock’s 50 day simple moving average is $506.00 and its two-hundred day simple moving average is $523.53. The firm has a market cap of $172.23 billion, a PE ratio of 67.01, a P/E/G ratio of 5.02 and a beta of 1.59.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The business had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. During the same quarter in the prior year, the firm posted $1.78 EPS. The business’s quarterly revenue was up 21.4% compared to the same quarter last year. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.